Skip to main content
Retour
Watch Compare

Can-Fite BioPharma Ltd.

Qualité des données : 100%
CANF
NYSE Manufacturing Chemicals
2,99 €
▼ 0,09 € (-2,82%)
Cap. Boursière: 7,02 M
Prix
2,99 €
Cap. Boursière
7,02 M
Fourchette du Jour
2,94 € — 3,16 €
Fourchette 52 Semaines
2,94 € — 36,40 €
Volume
54 522
Ouverture 3,07 €
Moyenne 50J / 200J
4,05 €
26,02% below
Moyenne 50J / 200J
9,54 €
68,62% below

Quick Summary

Points Clés

Revenue declined -16,99% annually over 5 years
Negative free cash flow of -8,95 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 22,92%
Capital efficient — spends only 0,49% of revenue on capex

Croissance

Revenue Growth (5Y)
-16,99%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-39,91%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-295,00%
En dessous de la moyenne du secteur (-53,41%)
ROIC-164,88%
Net Margin-2426,67%
Op. Margin-2456,79%

Sécurité

Debt / Equity
N/A
Current Ratio3,60
Interest Coverage-35,04

Valorisation

PE (TTM)
-0,71
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio1,68
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,7 -1,5
P/B 1,7 1,6
ROE % -295,0 -53,4
Net Margin % -2426,7 -41,5
Rev Growth 5Y % -17,0 1,8
D/E — 0,3

ETFs Holding This Stock

AVEE logo AVEE Avantis Emerging Markets Small Cap Equity ETF
0,05% weight
AVES logo AVES Avantis Emerging Markets Value ETF
0,04% weight
IND logo IND Xtrackers Nifty 500 India ETF
0,04% weight
AVSE logo AVSE Avantis Responsible Emerging Markets Equity ETF
0,03% weight
AVXC logo AVXC Avantis Emerging Markets ex-China Equity ETF
0,02% weight
WLCTX WLCTX
0,01% weight
WLTTX WLTTX
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -39,91% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -16,99% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 405 000,0 Net Income (TTM) -9,83 M
ROE -295,00% ROA -144,08%
Gross Margin N/A Operating Margin -2456,79%
Net Margin -2426,67% Free Cash Flow (TTM) -8,95 M
ROIC -164,88% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,60
Interest Coverage -35,04 Asset Turnover 0,06
Working Capital 5,50 M Tangible Book Value 4,18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,71 Forward P/E N/A
P/B Ratio 1,68 P/S Ratio 17,34
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -127,44%
Market Cap 7,02 M Enterprise Value 569 538,0
Per Share
EPS (Diluted TTM) -5,97 Revenue / Share 0,17
FCF / Share -3,81 OCF / Share -3,81
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,49% FCF Conversion 91,08%
SBC-Adj. FCF -9,63 M Growth Momentum -22,92

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 405 000,0 674 000,0 — 810 000,0 853 000,0
Net Income -9,83 M -7,88 M -7,63 M -10,17 M -12,62 M
EPS (Diluted) -5,97 0,00 -0,01 -0,01 —
Gross Profit — — — — —
Operating Income -9,95 M -8,13 M -8,20 M -10,10 M -12,84 M
EBITDA — — — — —
R&D Expenses 6,69 M 5,76 M 5,98 M 7,76 M 9,85 M
SG&A Expenses — — — 263 000,0 —
D&A 24 000,0 — — 14 000,0 14 000,0
Interest Expense 284 000,0 -291 000,0 — -77 000,0 227 000,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 9,51 M 9,12 M 9,99 M 9,28 M 20,25 M
Total Liabilities — — — — —
Shareholders' Equity 5,59 M 5,44 M 6,24 M 4,47 M 14,38 M
Total Debt — — — — —
Cash & Equivalents 5,53 M 4,83 M 4,28 M 2,98 M 4,39 M
Current Assets 9,44 M 8,98 M 9,91 M 9,16 M 20,07 M
Current Liabilities 2,73 M 2,05 M 2,02 M 2,50 M 2,73 M